Avita Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.3M | 81k | 16.03 |
| 2023-12-31 | $381k | 28k | 13.72 |
| 2023-09-30 | $329k | 23k | 14.61 |
| 2023-06-30 | $556k | 33k | 17.01 |
| 2023-03-31 | $1.1M | 77k | 13.97 |
| 2022-06-30 | $87k | 18k | 4.76 |
| 2022-03-31 | $213k | 25k | 8.51 |
| 2021-12-31 | $978k | 82k | 11.98 |
| 2021-09-30 | $185k | 11k | 17.68 |
| 2021-03-31 | $2.0M | 99k | 19.82 |